Related Experiment Video
Updated: Aug 22, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients
P Wilfredo Canchis1, Herman T Yee, M Isabel Fiel
1Center for the Study of Hepatitis C, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Insights
HIV coinfection with hepatitis C virus (HCV) leads to fewer liver CD4 cells and more lymphocyte apoptosis. This may negatively impact the progression of HCV infection in coinfected patients.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) exacerbates liver disease.
- HIV/HCV coinfection is linked to increased liver inflammation, fibrosis, and poorer treatment outcomes.
Purpose of the Study:
- To investigate intrahepatic immune cell and hepatocyte differences in patients coinfected with HIV and HCV versus those with HCV alone.
- To correlate intrahepatic findings with peripheral viral load and CD4 counts.
Main Methods:
- Quantification of intrahepatic lymphocytes and hepatocytes by a single pathologist in portal and lobular areas.
- Comparison of cell counts between HCV-monoinfected and HIV/HCV-coinfected patient groups (n=41 vs. n=38).
Main Results:
- Coinfected patients showed significantly fewer portal CD4 cells (4.97 vs. 10.58 cells/HPF) and more lobular apoptotic lymphocytes (0.64 vs. 0.16 cells/HPF).
- Portal CD4 cell counts did not correlate with peripheral CD4 counts.
- Increased portal proliferative hepatocytes were observed in coinfected patients with high HIV RNA levels (>400 copies/mL).
Conclusions:
- HIV coinfection is associated with distinct intrahepatic immune alterations, including reduced portal CD4 cells and increased lymphocyte apoptosis.
- These changes may influence the natural course and progression of hepatitis C virus infection in coinfected individuals.
Abstract:
Coinfection with HIV and hepatitis C virus (HCV)-specific immune responses, increases hepatic inflammation, accelerates hepatic fibrosis, and is associated with deceased treatment responses. We quantified intrahepatic lymphocyte and hepatocyte phenotypes in HCV-infected patients with (n = 38) and without (n = 41) HIV infection. A single pathologist counted positive cells in 5 portal and 5 lobular areas. Coinfected patients had 6.81 +/- 1.9 fewer CD4 cells per portal field (10.58 +/- 1.12 vs. 4.97 +/- 1.09 cells/high-power field [HPF]; P < 0.001) and 0.48 +/- 0.15 more apoptotic lymphocytes per lobular field (0.16 +/- 0.06 vs. 0.64 +/- 0.15 cell/HPF; P = 0.002) than monoinfected patients. The number of portal CD4 cells was not associated with the peripheral CD4 cell number. Portal and lobular CD8 cells did not differ between the 2 groups. Portal proliferative hepatocytes were increased in coinfected patients with HIV RNA levels of >400 copies/mL (1.13 +/- 0.32 cells/HPF; P = 0.01) compared with those with undetectable HIV RNA (0.46 +/- 0.09 cell/HPF) and monoinfected patients (0.45 +/- 0.08 cell/HPF). In conclusion, HIV coinfection is associated with fewer portal CD4 cells and increased lobular lymphocyte apoptosis that may impact on the natural history of HCV infection.
Related Concept Videos
Retrovirus Life Cycles
Hepatitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Viral Hepatitis I: Introduction
